Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2026
Anodal cerebellar tDCS does not alter beta oscillations or corticokinematic coherence in Friedreich's ataxia and healthy participants.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Georgiev Christian, Bourguignon Mathieu, Mongold Scott J, Moumdjian Lousin, Cabaraux Pierre, Naeije Gilles
Аннотация
OBJECTIVE: To evaluate the effect of anodal cerebellar transcranial Direct Current Stimulation (ctDCS) on the excitability of the sensorimotor cortex (SM1), in Friedreich's ataxia (FA) and healthy participants.
METHODS: Nineteen FA and 17 healthy participants underwent a 10-day non-sham controlled anodal ctDCS intervention. SM1 excitability pre and post ctDCS was quantified with Magnetoencephalography-assessed resting beta amplitude and power, beta burst rate and duration, and the aperiodic component of oscillatory power. Cortical processing of proprioception pre and post ctDCS was assessed with Corticokinematic Coherence (CKC). FA patients' motor symptoms pre and post ctDCS were assessed with the Scale for the Assessment and Rating of Ataxia (SARA).
RESULTS: The resting beta amplitude, power, burst rate and duration, and the aperiodic component of oscillatory power did not differ significantly between FA and healthy participants. In both groups, these measures were not significantly affected by the anodal ctDCS. CKC was significantly lower in FA compared to healthy participants, however, it was not significantly affected by the ctDCS. In the FA group, a significant improvement in SARA score was found post ctDCS.
CONCLUSIONS: Anodal ctDCS improved FA motor symptom severity without altering SM1 excitability.
SIGNIFICANCE: Anodal ctDCS has a therapeutic effect in FA, however, the neurophysiology of this effect is complex and requires further investigation.
METHODS: Nineteen FA and 17 healthy participants underwent a 10-day non-sham controlled anodal ctDCS intervention. SM1 excitability pre and post ctDCS was quantified with Magnetoencephalography-assessed resting beta amplitude and power, beta burst rate and duration, and the aperiodic component of oscillatory power. Cortical processing of proprioception pre and post ctDCS was assessed with Corticokinematic Coherence (CKC). FA patients' motor symptoms pre and post ctDCS were assessed with the Scale for the Assessment and Rating of Ataxia (SARA).
RESULTS: The resting beta amplitude, power, burst rate and duration, and the aperiodic component of oscillatory power did not differ significantly between FA and healthy participants. In both groups, these measures were not significantly affected by the anodal ctDCS. CKC was significantly lower in FA compared to healthy participants, however, it was not significantly affected by the ctDCS. In the FA group, a significant improvement in SARA score was found post ctDCS.
CONCLUSIONS: Anodal ctDCS improved FA motor symptom severity without altering SM1 excitability.
SIGNIFICANCE: Anodal ctDCS has a therapeutic effect in FA, however, the neurophysiology of this effect is complex and requires further investigation.